{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:52:11Z","timestamp":1781927531165,"version":"3.54.5"},"reference-count":58,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j124","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:08:54Z","timestamp":1760566134000},"page":"145-154","source":"Crossref","is-referenced-by-count":0,"title":["Denosumab for the Treatment of Aggressive Recurrent Central Giant Cell Granuloma of the Maxilla in a Patient with Osteoglophonic Dysplasia"],"prefix":"10.1620","volume":"269","author":[{"given":"Komalam","family":"Mugunam","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universiti Kebangsaan Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roszalina","family":"Ramli","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universiti Kebangsaan Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aulestia-Viera, P.V., Santos-Silva A.R., Martin R.M., Santos C.M.D.S., Machado G.G.&Rocha A.C.(2022)Positive outcomes of Denosumab in the treatment of central giant cell lesions: Case series.Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.<\/i>,134,e107.","DOI":"10.1016\/j.oooo.2022.01.146"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Azouz, E.M.&Kozlowski, K. (1997) Osteoglophonic dysplasia: appearance and progression of multiple nonossifying fibromata. Pediatr. Radiol.<\/i>, 27, 75-78. https:\/\/doi.org\/10.1007\/s002470050069","DOI":"10.1007\/s002470050069"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Beighton, P.(1989) Osteoglophonic dysplasia. J. Med. Genet.<\/i>, 26, 572-576. https:\/\/doi.org\/10.1136\/jmg.26.9.572","DOI":"10.1136\/jmg.26.9.572"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Boye, K., Jebsen, N.L., Zaikova, O., Knobel, H., Londalen, A.M., Trovik, C.S., Monge, O.R.&Hall, K.S. (2017) Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort. Acta Oncol.<\/i>, 56, 479-483. https:\/\/doi.org\/10.1080\/0284186X.2016.1278305","DOI":"10.1080\/0284186X.2016.1278305"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Bredell, M., Rordorf, T., Kroiss, S., Rucker, M., Zweifel, D.F.&Rostetter, C. (2018) Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study. J. Oral Maxillofac. Surg.<\/i>, 76, 775-784. https:\/\/doi.org\/10.1016\/j.joms.2017.09.013","DOI":"10.1016\/j.joms.2017.09.013"},{"key":"6","doi-asserted-by":"publisher","unstructured":"Camarini, C.&de Souza Tolentino, E. (2022) Non-surgical treatment as an alternative for the management of central giant cell granuloma: a systematic review. Clin. Oral Investig.<\/i>, 26, 2111-2132. https:\/\/doi.org\/10.1007\/s00784-021-04193-z","DOI":"10.1007\/s00784-021-04193-z"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Cheng, Y.Y., Huang, L., Lee, K.M., Xu, J.K., Zheng, M.H.&Kumta, S.M. (2004) Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif. Tissue Int.<\/i>, 75, 71-77. https:\/\/doi.org\/10.1007\/s00223-004-0120-2","DOI":"10.1007\/s00223-004-0120-2"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Chien, M.C., Mascarenhas, L., Hammoudeh, J.A.&Venkatramani, R. (2015) Zoledronic Acid for the Treatment of Children With Refractory Central Giant Cell Granuloma. J. Pediatr. Hematol. Oncol.<\/i>, 37, e399-401. https:\/\/doi.org\/10.1097\/MPH.0000000000000380","DOI":"10.1097\/MPH.0000000000000380"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Cleven, A.H.G., Schreuder, W.H., Groen, E., de Lange, J., Briaire-de Bruijn, I.H.&Bovee, J. (2022) Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours. Virchows Arch.<\/i>, 481, 671-675. https:\/\/doi.org\/10.1007\/s00428-022-03341-4","DOI":"10.1007\/s00428-022-03341-4"},{"key":"10","doi-asserted-by":"publisher","unstructured":"de Lange, J., van den Akker, H.P.&van den Berg, H. (2007) Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.<\/i>, 104, 603-615. https:\/\/doi.org\/10.1016\/j.tripleo.2007.04.003","DOI":"10.1016\/j.tripleo.2007.04.003"},{"key":"11","doi-asserted-by":"publisher","unstructured":"Drake, M.T., Clarke, B.L.&Khosla, S. (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin. Proc.<\/i>, 83, 1032-1045. https:\/\/doi.org\/10.4065\/83.9.1032","DOI":"10.4065\/83.9.1032"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Erdogan, K.E., Devec, I.M., Paydas, S.&Gonlusen, G. (2016) Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme. Pol. J. Pathol.<\/i>, 67, 392-397. https:\/\/doi.org\/10.5114\/pjp.2016.65873","DOI":"10.5114\/pjp.2016.65873"},{"key":"13","unstructured":"Fairbank, H.A.T. (1951) An atlas of general affections of the skeleton<\/i>, E. & S. Livingstone, Edinburgh."},{"key":"14","doi-asserted-by":"publisher","unstructured":"Farrow, E.G., Davis, S.I., Mooney, S.D., Beighton, P., Mascarenhas, L., Gutierrez, Y.R., Pitukcheewanont, P.&White, K.E. (2006) Extended mutational analyses of FGFR1 in osteoglophonic dysplasia. Am. J. Med. Genet. A<\/i>, 140, 537-539. https:\/\/doi.org\/10.1002\/ajmg.a.31106","DOI":"10.1002\/ajmg.a.31106"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Franklin, C.D., Craig, G.T.&Smith, C.J. (1979) Quantitative analysis of histological parameters in giant cell lesions of the jaws and long bones. Histopathology<\/i>, 3, 511-522. https:\/\/doi.org\/10.1111\/j.1365-2559.1979.tb03032.x","DOI":"10.1111\/j.1365-2559.1979.tb03032.x"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Gaston, C.L., Grimer, R.J., Parry, M., Stacchiotti, S., Dei Tos, A.P., Gelderblom, H., Ferrari, S., Baldi, G.G., Jones, R.L., Chawla, S., Casali, P., LeCesne, A., Blay, J.Y., Dijkstra, S.P., Thomas, D.M.&Rutkowski, P. (2016) Current Status and Unanswered Questions on the Use Of Denosumab in Giant Cell Tumor of Bone. Clin. Sarcoma Res.<\/i>, 6, 15. https:\/\/doi.org\/10.1186\/s13569-016-0056-0","DOI":"10.1186\/s13569-016-0056-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Gigliotti, J., Alghamdi, O., El-Hakim M.&Makhoul, N. (2015) Central giant cell granuloma of the mandibular condyle: A case report, literature review, and discussion of treatment. Oral and Maxillofacial Surgery Cases<\/i>, 1, 42-46.","DOI":"10.1016\/j.omsc.2015.08.001"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Gomes, C.C., Diniz, M.G., Bastos, V.C., Bernardes, V.F.&Gomez, R.S. (2020) Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing. J. Pathol.<\/i>, 250, 126-133. https:\/\/doi.org\/10.1002\/path.5365","DOI":"10.1002\/path.5365"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Kaban, L.B., Troulis, M.J., Ebb, D., August, M., Hornicek, F.J.&Dodson, T.B. (2002) Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J. Oral Maxillofac. Surg.<\/i>, 60, 1103-1111; discussion 1111-1103. https:\/\/doi.org\/10.1053\/joms.2002.34975","DOI":"10.1053\/joms.2002.34975"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Kaffe, I., Ardekian, L., Taicher, S., Littner, M.M.&Buchner, A. (1996) Radiologic features of central giant cell granuloma of the jaws. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.<\/i>, 81, 720-726. https:\/\/doi.org\/10.1016\/s1079-2104(96)80079-5","DOI":"10.1016\/S1079-2104(96)80079-5"},{"key":"21","doi-asserted-by":"publisher","unstructured":"Katsikeris, N., Kakarantza-Angelopoulou, E.&Angelopoulos, A.P. (1988) Peripheral giant cell granuloma. Clinicopathologic study of 224 new cases and review of 956 reported cases. Int. J. Oral Maxillofac. Surg.<\/i>, 17, 94-99. https:\/\/doi.org\/10.1016\/s0901-5027(88)80158-9","DOI":"10.1016\/S0901-5027(88)80158-9"},{"key":"22","doi-asserted-by":"publisher","unstructured":"Keats, T.E., Smith, T.H.&Sweet, D.E. (1975) Craniofacial dysotosis with fibrous metaphyseal deffects. Am. J. Roentgenol. Radium Ther. Nucl. Med.<\/i>, 124, 271-275. https:\/\/doi.org\/10.2214\/ajr.124.2.271","DOI":"10.2214\/ajr.124.2.271"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Kelley, R.I., Borns, P.F., Nichols, D.&Zackai, E.H. (1983) Osteoglophonic dwarfism in two generations. J. Med. Genet.<\/i>, 20, 436-440. https:\/\/doi.org\/10.1136\/jmg.20.6.436","DOI":"10.1136\/jmg.20.6.436"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Kumar, A., Chong, Y.T., Jamil, K.&Rusli, E. (2021) Severe presentation of non-ossifying fibroma of the femur in osteoglophonic dysplasia. BMJ Case Rep.<\/i>, 14, e245415. https:\/\/doi.org\/10.1136\/bcr-2021-245415","DOI":"10.1136\/bcr-2021-245415"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Kuthiroly, S., Yesodharan, D., Ghosh, A., White, K.E.&Nampoothiri, S. (2017) Osteoglophonic Dysplasia: Phenotypic and Radiological Clues. J. Pediatr. Genet.<\/i>, 6, 247-251. https:\/\/doi.org\/10.1055\/s-0037-1602816","DOI":"10.1055\/s-0037-1602816"},{"key":"26","doi-asserted-by":"publisher","unstructured":"Li, F., Huynh, H., Li, X., Ruddy, D.A., Wang, Y., Ong, R., Chow, P., Qiu, S., Tam, A., Rakiec, D.P., Schlegel, R., Monahan, J.E.&Huang, A. (2015) FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors. Cancer Discov.<\/i>, 5, 438-451. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0763","DOI":"10.1158\/2159-8290.CD-14-0763"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Liu, B., Yu, S.F.&Li, T.J. (2003) Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J. Oral Pathol. Med.<\/i>, 32, 367-375. https:\/\/doi.org\/10.1034\/j.1600-0714.2003.00126.x","DOI":"10.1034\/j.1600-0714.2003.00126.x"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Lu, J., Hu, D., Zhang, Y., Ma, C., Shen, L.&Shuai, B. (2023) Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials. Front. Oncol.<\/i>, 13, 1133828. https:\/\/doi.org\/10.3389\/fonc.2023.1133828","DOI":"10.3389\/fonc.2023.1133828"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Mariz, B., Migliorati, C.A., Alves, F.A., Penteado, F.M., Carvalho, N.P.F., Santos-Silva, A.R.&Rocha, A.C. (2021) Successful denosumab treatment for central giant cell granuloma in a 9-year-old child. Spec. Care Dentist.<\/i>, 41, 519-525. https:\/\/doi.org\/10.1111\/scd.12588","DOI":"10.1111\/scd.12588"},{"key":"30","doi-asserted-by":"publisher","unstructured":"Martins, C.A., Leyhausen, G., Volk, J.&Geurtsen, W. (2015) Effects of alendronate on osteoclast formation and activity in vitro. J. Endod.<\/i>, 41, 45-49. https:\/\/doi.org\/10.1016\/j.joen.2014.07.010","DOI":"10.1016\/j.joen.2014.07.010"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Marzin, P., Baujat, G., Gensburger, D., Huber, C., Bole, C., Panuel, M., Finidori, G., De la Dure, M.&Cormier-Daire, V. (2020) Heterozygous FGFR1 mutation may be responsible for an incomplete form of osteoglophonic dysplasia, characterized only by radiolucent bone lesions and teeth retentions. Eur. J. Med. Genet.<\/i>, 63, 103729. https:\/\/doi.org\/10.1016\/j.ejmg.2019.103729","DOI":"10.1016\/j.ejmg.2019.103729"},{"key":"32","doi-asserted-by":"publisher","unstructured":"Mohammad, K.S.&Akhund, S.A. (2024) From Tumor to Bone: Growth Factor Receptors as Key Players in Cancer Metastasis. Front. Biosci.<\/i> (Landmark Ed.<\/i>), 29, 184. https:\/\/doi.org\/10.31083\/j.fbl2905184","DOI":"10.31083\/j.fbl2905184"},{"key":"33","doi-asserted-by":"publisher","unstructured":"Moore, K.J., Sheedy, F.J.&Fisher, E.A. (2013) Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol.<\/i>, 13, 709-721. https:\/\/doi.org\/10.1038\/nri3520","DOI":"10.1038\/nri3520"},{"key":"34","doi-asserted-by":"publisher","unstructured":"Naidu, A., Malmquist, M.P., Denham, C.A.&Schow, S.R. (2014) Management of central giant cell granuloma with subcutaneous denosumab therapy. J. Oral Maxillofac. Surg.<\/i>, 72, 2469-2484. https:\/\/doi.org\/10.1016\/j.joms.2014.06.456","DOI":"10.1016\/j.joms.2014.06.456"},{"key":"35","doi-asserted-by":"publisher","unstructured":"Othman, A.A., Babcock, H.E., Gill, C.S., Fraser, J.L., Regier, D.S., Kaur, R., Simpson, K.L.&Ferreira, C.R. (2025) New Phenotypic Features in FGFR1-Related Osteoglophonic Dysplasia. Am. J. Med. Genet. A<\/i>, 197, e64092. https:\/\/doi.org\/10.1002\/ajmg.a.64092","DOI":"10.1002\/ajmg.a.64092"},{"key":"36","doi-asserted-by":"publisher","unstructured":"Pilard, C., Roncarati, P., Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Poulain, F., Bruyere, D., Lebeau, A., Hendrick, E., Crake, R., Peiffer, R., Nokin, M.J., Peulen, O., et al.(2025) RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells. J. Immunother. Cancer<\/i>, 13, e010753. https:\/\/doi.org\/10.1136\/jitc-2024-010753","DOI":"10.1136\/jitc-2024-010753"},{"key":"37","doi-asserted-by":"publisher","unstructured":"Pittman, K., Antill, Y.C., Goldrick, A., Goh, J.&de Boer, R.H. (2017) Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures. Asia Pac. J. Clin. Oncol.<\/i>, 13, 266-276. https:\/\/doi.org\/10.1111\/ajco.12517","DOI":"10.1111\/ajco.12517"},{"key":"38","doi-asserted-by":"publisher","unstructured":"Pogrel, M.A.&Hossaini-Zadeh, M. (2021) Denosumab for the management of central giant cell granuloma of the jaws-a case series. Int. J. Oral Maxillofac. Surg.<\/i>, 50, 1019-1022. https:\/\/doi.org\/10.1016\/j.ijom.2020.12.013","DOI":"10.1016\/j.ijom.2020.12.013"},{"key":"39","doi-asserted-by":"publisher","unstructured":"Roberts, T.S., Stephen, L.&Beighton, P. (2006) Osteoglophonic dysplasia: dental and orthodontic implications. Orthod. Craniofac. Res.<\/i>, 9, 153-156. https:\/\/doi.org\/10.1111\/j.1601-6343.2006.00369.x","DOI":"10.1111\/j.1601-6343.2006.00369.x"},{"key":"40","doi-asserted-by":"publisher","unstructured":"Roitman, P.D., Jauk, F., Farfalli, G.L., Albergo, J.I.&Aponte-Tinao, L.A. (2017) Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls. Hum. Pathol.<\/i>, 63, 89-97. https:\/\/doi.org\/10.1016\/j.humpath.2017.02.008","DOI":"10.1016\/j.humpath.2017.02.008"},{"key":"41","doi-asserted-by":"publisher","unstructured":"Rovelo, M.O., Kim, R., Mascarenhas, L., Hammoudeh, J.&Urata, M.M. (2009) Recurrent and refractory giant cell tumor of the jaw. J. Craniofac. Surg.<\/i>, 20, 2245-2248. https:\/\/doi.org\/10.1097\/SCS.0b013e3181bf866e","DOI":"10.1097\/SCS.0b013e3181bf866e"},{"key":"42","doi-asserted-by":"publisher","unstructured":"Santos, H., Campos, P., Alves, R.&Torrado, A. (1988) Osteoglophonic dysplasia: a new case. Eur. J. Pediatr.<\/i>, 147, 547-549. https:\/\/doi.org\/10.1007\/BF00441988","DOI":"10.1007\/BF00441988"},{"key":"43","doi-asserted-by":"publisher","unstructured":"Schreuder, W.H., Coumou, A.W., Kessler, P.A.&de Lange, J. (2014) Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab. J. Oral Maxillofac. Surg.<\/i>, 72, 1301-1309. https:\/\/doi.org\/10.1016\/j.joms.2014.02.017","DOI":"10.1016\/j.joms.2014.02.017"},{"key":"44","doi-asserted-by":"publisher","unstructured":"Shankar, V.N., Ajila, V.&Kumar, G. (2010) Osteoglophonic dysplasia: a case report. J. Oral Sci.<\/i>, 52, 167-171. https:\/\/doi.org\/10.2334\/josnusd.52.167","DOI":"10.2334\/josnusd.52.167"},{"key":"45","doi-asserted-by":"publisher","unstructured":"Sklower Brooks, S., Kassner, G., Qazi, Q., Keogh, M.J.&Gorlin, R.J. (1996) Osteoglophonic dysplasia: review and further delineation of the syndrome. Am. J. Med. Genet.<\/i>, 66, 154-162. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19961211)66:2<154::AID-AJMG6>3.0.CO;2-R","DOI":"10.1002\/(SICI)1096-8628(19961211)66:2<154::AID-AJMG6>3.0.CO;2-R"},{"key":"46","doi-asserted-by":"publisher","unstructured":"Slootweg, P.J.(1989) Comparison of giant cell granuloma of the jaw and non-ossifying fibroma. J. Oral Pathol. Med.<\/i>, 18, 128-132. https:\/\/doi.org\/10.1111\/j.1600-0714.1989.tb00750.x","DOI":"10.1111\/j.1600-0714.1989.tb00750.x"},{"key":"47","doi-asserted-by":"publisher","unstructured":"Sow, A.J., Ramli, R., Latiff, Z.A., Ichikawa, S., Gray, A.K., Nordin, R., Abd Jabar, M.N., Primuharsa Putra, S.H., Siar, C.H.&Econs, M.J. (2010) Osteoglophonic dysplasia: A \u2018common\u2019 mutation in a rare disease. Clin. Genet.<\/i>, 78, 197-198. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01382.x","DOI":"10.1111\/j.1399-0004.2010.01382.x"},{"key":"48","doi-asserted-by":"publisher","unstructured":"Szymczyk, J., Sochacka, M., Chudy, P., Opalinski, L., Otlewski, J.&Zakrzewska, M. (2022) FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms. Front. Oncol.<\/i>, 12, 1011762. https:\/\/doi.org\/10.3389\/fonc.2022.1011762","DOI":"10.3389\/fonc.2022.1011762"},{"key":"49","doi-asserted-by":"publisher","unstructured":"Tarsitano, A., Del Corso, G., Pizzigallo, A.&Marchetti, C. (2015) Aggressive Central Giant Cell Granuloma of the Mandible Treated With Conservative Surgical Enucleation and Interferon-alpha-2a: Complete Remission With Long-Term Follow-Up. J. Oral Maxillofac. Surg.<\/i>, 73, 2149-2154. https:\/\/doi.org\/10.1016\/j.joms.2015.04.029","DOI":"10.1016\/j.joms.2015.04.029"},{"key":"50","doi-asserted-by":"publisher","unstructured":"Thomas, D., Henshaw, R., Skubitz, K., Chawla, S., Staddon, A., Blay, J.Y., Roudier, M., Smith, J., Ye, Z., Sohn, W., Dansey, R.&Jun, S. (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol.<\/i>, 11, 275-280. https:\/\/doi.org\/10.1016\/S1470-2045(10)70010-3","DOI":"10.1016\/S1470-2045(10)70010-3"},{"key":"51","doi-asserted-by":"publisher","unstructured":"Tse, L.F., Wong, K.C., Kumta, S.M., Huang, L., Chow, T.C.&Griffith, J.F. (2008) Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone<\/i>, 42, 68-73. https:\/\/doi.org\/10.1016\/j.bone.2007.08.038","DOI":"10.1016\/j.bone.2007.08.038"},{"key":"52","doi-asserted-by":"publisher","unstructured":"Ud Din, N., Umer, M.&Park, Y.K. (2020) Histomorphometric Analysis of Pre- and Post-Denosumab-Treated Giant Cell Tumor of Bone. Int. J. Surg. Pathol.<\/i>, 28, 859-867. https:\/\/doi.org\/10.1177\/1066896920920716","DOI":"10.1177\/1066896920920716"},{"key":"53","doi-asserted-by":"publisher","unstructured":"Waldron, C.A.(1953) Giant cell tumors of the jawbones. Oral Surg. Oral Med. Oral Pathol.<\/i>, 6, 1055-1064. https:\/\/doi.org\/10.1016\/0030-4220(53)90218-7","DOI":"10.1016\/0030-4220(53)90218-7"},{"key":"54","doi-asserted-by":"publisher","unstructured":"Walsh, J.P., Ward, L.C., Stewart, G.O., Will, R.K., Criddle, R.A., Prince, R.L., Stuckey, B.G., Dhaliwal, S.S., Bhagat, C.I., Retallack, R.W., Kent, G.N., Drury, P.J., Vasikaran, S.&Gutteridge, D.H. (2004) A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget\u2019s disease of bone. Bone<\/i>, 34, 747-754. https:\/\/doi.org\/10.1016\/j.bone.2003.12.011","DOI":"10.1016\/j.bone.2003.12.011"},{"key":"55","doi-asserted-by":"publisher","unstructured":"White, K.E., Cabral, J.M., Davis, S.I., Fishburn, T., Evans, W.E., Ichikawa, S., Fields, J., Yu, X., Shaw, N.J., McLellan, N.J., McKeown, C., Fitzpatrick, D., Yu, K., Ornitz, D.M.&Econs, M.J. (2005) Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am. J. Hum. Genet.<\/i>, 76, 361-367. https:\/\/doi.org\/10.1086\/427956","DOI":"10.1086\/427956"},{"key":"56","doi-asserted-by":"publisher","unstructured":"Wojcik, J., Rosenberg, A.E., Bredella, M.A., Choy, E., Hornicek, F.J., Nielsen, G.P.&Deshpande, V. (2016) Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone. Am. J. Surg. Pathol.<\/i>, 40, 72-80. https:\/\/doi.org\/10.1097\/PAS.0000000000000506","DOI":"10.1097\/PAS.0000000000000506"},{"key":"57","doi-asserted-by":"publisher","unstructured":"Xu, S.F., Adams, B., Yu, X.C.&Xu, M. (2013) Denosumab and giant cell tumour of bone-a review and future management considerations. Curr. Oncol.<\/i>, 20, e442-447. https:\/\/doi.org\/10.3747\/co.20.1497","DOI":"10.3747\/co.20.1497"},{"key":"58","doi-asserted-by":"publisher","unstructured":"Zou, Y., Lin, H., Chen, W., Chang, L., Cai, S., Lu, Y.G.&Xu, L. (2022) Abnormal eruption of teeth in relation to FGFR1 heterozygote mutation: a rare case of osteoglophonic dysplasia with 4-year follow-up. BMC Oral Health<\/i>, 22, 36. https:\/\/doi.org\/10.1186\/s12903-022-02069-6","DOI":"10.1186\/s12903-022-02069-6"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J124\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:22:46Z","timestamp":1781925766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J124\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j124","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J124"}}